Infectious disease research bolstered by Hospitals of Regina Foundation
To help protect Saskatchewan residents from emerging disease threats, Hospitals of Regina Foundation has invested $150,000 to help establish Canada’s Centre for Pandemic Research at USask's Vaccine and Infectious Disease Organization.
VIDO research provides insight into the immune response and possible long-term health impacts associated with COVID-19
One of the newest scientists at the University of Saskatchewan’s Vaccine and Infectious Disease Organization has published new research on potential lasting effects of COVID-19.
USask’s VIDO announces positive Phase 1 results for COVAC-2
The Vaccine and Infectious Disease Organization at the University of Saskatchewan announced positive interim results from their Phase 1 clinical trial for COVAC-2, VIDO’s COVID-19 subunit vaccine candidate.
Sask.-based research offers hope in unsettling times
Uncertain times require robust social sciences and humanities analysis, and leadership from scholars to discuss complex issues with the public.
Saskatchewan Blue Cross invests $150K to help establish USask’s VIDO as Canada’s Centre for Pandemic Research
The Vaccine and Infectious Disease Organization at the University of Saskatchewan is one step closer to establishing its Centre for Pandemic Research, thanks to a $150,000 donation from Saskatchewan Blue Cross.
Ministers Champagne, Joly and Carr highlight Budget 2021 biomanufacturing investments
Budget 2021 proposes to provide $59.2M to USask's VIDO, through Western Economic Diversification Canada’s Regional Economic Growth through Innovation program, to help it develop and manufacture bio-solutions such as vaccines and therapeutics.
Federal budget supports USask’s VIDO with $59.2M
Today the Government of Canada announced $59.2 million to VIDO to support the development of its vaccine candidates and the expansion of its research facilities, including a National Centre for Pandemic Research.
USask researchers seek to prevent liver disease, high blood pressure, and understand lifelong impacts of Zika virus
Three University of Saskatchewan researchers have been awarded a total of $1.87 million by the Canadian Institutes for Health Research (CIHR) for projects involving fatty liver disease, high blood pressure, and Zika virus.
Canada’s Global Nexus and VIDO join forces to combat COVID–19
Canada’s Global Nexus for Pandemics and Biological Threats at McMaster University and VIDO at USask are working together to accelerate vaccine and drug development, human clinical trials and create new diagnostic tools.
VIDO gains provincial support towards becoming a ‘Centre for Pandemic Research’
The Government of Saskatchewan committed $15 million to support the University of Saskatchewan’s Vaccine and Infectious Disease Organization’s position as a Centre for Pandemic Research.